Composition for making pathological tissues dehydration and/or contraction

a technology of pathological tissues and compositions, which is applied in the direction of drug compositions, iron sulfates, extracellular fluid disorders, etc., can solve the problem that the concentration of solutions cannot be too high, and achieve the effects of good substance effect, significant treatment effect, and convenient us

Inactive Publication Date: 2011-12-22
TAM KUOK LEONG +2
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention is a use invention. Ferric subsulfate and polyferric sulfate are traditionally used as water treatment agent. The present inventor surprisingly discovered the medical value of these substances. A large amount of experiments were performed over years and demonstrated very good effect of the substances. These compositions are cost-effective, convenient to use and have significant effects in treatment of vascular diseases such as hemorrhoids, hemangiomas, hematomas (including hematomas caused by brain hemorrhage), thrombi and varices, and topical traumas such as bleeding and edemas. The compositions are also capable of killing various tumor cells by targeted injection.

Problems solved by technology

Of course, the concentration of the solution cannot be too high because the solution becomes saturated when the weight percent of the active component reaches about 45%.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 2

A small amount of solid powder of polyferric sulfate is applied onto a bleeding traumatic wound. The wound quickly forms a scab within 5 seconds, but the patient feels a bit painful.

It is proved that both ferric subsulfate and polyferric sulfate can cause traumatic wound to quickly form a scab. These two substances do not react with each other, and thus it is expected that their mixture has the same function.

example 3

60 grams of solid powder of ferric subsulfate are well mixed with 40 grams of medical starch. A small amount of the mixture is applied onto a bleeding traumatic wound. The wound is further bound up by gauze. The wound forms a scab after 10 minutes, and the patient feels less painful.

example 4

35 grams of solid powder of ferric subsulfate are well mixed with 65 grams of medical silicon dioxide. A small amount of the mixture is applied onto a bleeding traumatic wound. The wound is further bound up by gauze. The wound forms a scab after half an hour, and the patient feels less painful.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
wt. %aaaaaaaaaa
wt. %aaaaaaaaaa
weightaaaaaaaaaa
Login to view more

Abstract

The present invention provides a pharmaceutical composition for dehydrating and atrophying pathological tissues comprising ferric subsulfate, polyferric sulfate or a mixture thereof is disclosed. Ferric subsulfate and polyferric sulfate are traditionally used as water treatment agent. The inventor surprisingly discovered the medical value of these substances. The compositions are cost-effective, convenient to use and have significant effects in treatment of vascular diseases such as hemorrhoids, hemangiomas, hematomas (including hematomas caused by brain hemorrhage), thrombi and varices, and topical traumas such as bleeding and edemas. The compositions are also capable of killing various tumor cells by targeted injection.

Description

CROSS-REFERENCE TO RELATED APPLICATIONThe present application claims priority from Chinese patent application number 200810030331.4, entitled “PHARMACEUTICAL COMPOSITIONS FOR DEHYDRATING AND ATROPHYING PATHOLOGICAL TISSUES” and filed in the name of Kuok Leong TAM on Aug. 22, 2008. The entire content of the application is incorporated herein by reference.FIELD OF THE INVENTIONThe present invention relates to pharmaceutical compositions for dehydrating and atrophying pathological tissues.BACKGROUND OF THE INVENTIONFerric subsulfate, a compound having a molecular formula Fe4(OH)2(SO4)5, is a pale-yellow particle when it is in solid form. The particle is easily soluble in water to form a reddish-brown solution which can be crystallized and solidified at low temperature. The compound is obtained by reacting ferrous sulfate with heated dilute sulfuric acid and dilute nitric acid, and normally used as mordant or waste water treatment agent.Polyferric sulfate (PFS) is a polymer having a mol...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K33/26C01G49/14A61P29/00A61P23/02A61K35/56A61P17/02A61K35/65
CPCA61K31/167A61K31/245A61K33/26A61K45/06A61K35/65A61K2300/00A61P7/02A61P7/04A61P9/14A61P17/02A61P23/02A61P29/00A61P35/00A61P43/00
Inventor TAM, KUOK LEONGTAM, IO CHENGTAM, HIO MAN
Owner TAM KUOK LEONG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap